Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

More documents

Recommendations

Info

Bibliography62Mila M, Kruyer H, Glover G, et al, 1994. Molecularanalysis of the (CGG)n expansion in the FMR-1 genein 59 Spanish fragile X syndrome families. HumanGenetics;94:395–400.Mila M, Castellvi-Bel S, Sanchez A, Lazaro C, Villa M,Estivill X, 1996. Mosaicism for the fragile X syndromefull mutation and deletions within the CGG repeat ofthe FMR1 gene. J Med Genetics;33:338–40.Mingroni-Netto RC, Fernandes JG, Vianna-MorganteAM, 1994. Relationship of expansion of CGG repeatsand X-inactivation with expression of fra(X)(q27.3)in heterozygotes. Am J Med Genetics;51:443–6.Monckton DG, Caskey CT, 1995. Unstable triplet repeatdiseases [review]. Circulation;91:513–20.Montagnon M, Bogyo A, Deluchat C, et al, 1994.Transition from normal to premutated alleles infragile X syndrome results from a multistep process.Eur J Human Genetics;2:125–31.Mornet E, Chateau C, Taillandier A, et al, 1994.FRAXAC2 instability [letter]. Nature Genetics;7:122–3.Mornet E, Chateau C, Taillandier A, Simonbouy B, SerreJL, 1996. Recurrent and unexpected segregation of theFMR1 CGG repeat in a family with fragile-X syndrome.Human Genetics;97:512–15.Morris A, Morton NE, Collins A, Macpherson J, NelsonD, Sherman S, 1995. An n-allele model for progressiveamplification in the FMR1 locus. Proc Natl Acad SciUSA;92:4833–7.Morton NE, Macpherson JN, 1992. Population geneticsof the fragile-X syndrome: multiallelic model for theFMR1 locus. Proc Natl Acad Sci USA;89:4215–7.Morton JE, Rindl PM, Bullock S, Bundey S, Webb T,1995. Fragile-X syndrome is less common than previouslyestimated. J Med Genetics;32:144–5.Morton JE, Bundey S, Webb TP, MacDonald F, Rindl PM,Bullock S, 1997. Fragile X syndrome is less common thanpreviously estimated. J Med Genetics;34:1–5.Mueller OT, Hartsfield JK, Amar MJA, Gallardo LA,Kousseff BG,1995. Fragile-X syndrome – discordantlevels of CGG repeat mosaicism in two brothers.Am J Med Genetics;60:302–6.Mulley JC, Yu S, Gedeon AK, et al, 1992. Experiencewith direct molecular diagnosis of fragile X. J MedGenetics;29:368–74.Mulley JC, Yu S, Loesch DZ, et al, 1995. FRAXE andmental retardation. J Med Genetics;32:162–9.Murphy PD, Wilmot PL, Shapiro LR, 1992. Prenataldiagnosis of fragile X syndrome: results from parallelmolecular and cytogenetic studies. Am J MedGenetics;43:181–6.Murray A, Youings S, Dennis N, et al, 1996. Populationscreening at the FRAXA and FRAXE loci: molecularanalyses of boys with learning difficulties and theirmothers. Human Molec Genetics;5:727–35.Musumeci SA, Ferri R, Colognola M, Neir G, SanfilippoS, Bergonzi P, 1988. Prevalence of a novel epileptogenicEGG pattern in the Martin–Bell syndrome. Am J MedGenetics;30:207–12.Naber SP, 1995. Molecular diagnosis of fragileX syndrome. Diagnost Molec Pathol;4:158–61.Nagafuchi S, Yanagisawa H, Sato K, et al, 1994.Dentatorubral and pallidolusian atrophy expansionof an unstable CAG trinucleotide on chromosome12. Nature Genetics;6:14–18.Nakahori Y, 1995. The incidence of the fragile Xsyndrome [in Japanese – commentary on Nanbaet al, 1995]. Brain Dev;17:322.Nakahori Y, Knight SJ, Holland J, et al, 1991. Molecularheterogeneity of the fragile X syndrome. Nucleic AcidsRes;19:4355–9.Nanba E, Kohno Y, Matsuda A, et al, 1995. NonradioactiveDNA diagnosis for the fragile X syndrome inmentally-retarded Japanese males. Brain Dev;7:317–21.Nelson DL, 1995. The fragile X syndrome.Sem Cell Biol;6(1):5–11.Nelson DL, Warren ST, 1993. Trinucleotide repeatinstability: when and where [news – comment]?Nature Genetics;4:107–8.Nelson DL, Kunst CB, Lugenbeel KA, Ryder OA, WarrenST, Eichler EE, 1995. Evolution of the cryptic FMR1 CGGrepeat. Am J Human Genetics;57:211.Neri G, Sanfilippo S, Pavone L, et al, 1988. Thefragile X in Sicily: An epidemiological survey.Am J Med Genetics;30:665–72.Neville L, Cochrane J, Fitzgerald P, Kennedy M, 1995.Fragile-X mental-retardation syndrome – DNA diagnosisand carrier detection in New-Zealand families.NZ Med J;108:404–6.Nolin SL, Snider DA, Jenkins EC, et al, 1991. FragileX screening program in New York State. Am J MedGenetics;38:251–5.Nolin SL, Snider DA, Jenkins EC, et al, 1992. NewYork State screening program for fragile X syndrome:a progress report. Am J Med Genetics;43:328–32.Nolin SL, Glicksman A, Houck GE Jr, Brown WT,Dobkin CS, 1994. Mosaicism in fragile X affectedmales. Am J Med Genetics;51:509–12.Nolin SL, Glicksman A, Lewis FA, et al, 1995. Evidencefor a familial factor involved in CGG repeat expansionin fragile-X syndrome. Am J Human Genetics;57:965.Oberlé I, Rousseau F, Heitz D, et al, 1991. Instability of a550-base pair DNA segment and abnormal methylationin fragile X syndrome. Science;252:1097–1102.Oberlé I, Boue J, Croquette MF, Voelckel MA, MatteiMG, Mandel JL, 1992. Three families with high expressionof a fragile site at Xq27.3, lack of anomalies at theFMR-1 CpG island, and no clear phenotypic association.Am J Med Genetics;43:224–31.
Health Technology Assessment 1997; Vol. 1: No. 4Oostra BA, Jacky PB, Brown WT, Rousseau F, 1993.Guidelines for the diagnosis of fragile X syndrome.(National Fragile X Foundation.) J Med Genetics;30:410–3.Orr HT, Chung M-Y, Banfi S, et al, 1993. Expansion ofan unstable CAG repeat in spinocerebellar ataxia type1. Nature Genetics;4:221–6.Oudet C, Mornet E, Serre JL, et al, 1993a. Linkagedisequilibrium between the fragile X mutation andtwo closely linked CA repeats suggests that fragile Xchromosomes are derived from a small number offounder chromosomes. Am J Human Genetics;52:297–304.Oudet C, von Koskull H, Nordstrom AM, Peippo M,Mandel JL, 1993b. Striking founder effect for the fragileX syndrome in Finland. Eur J Human Genetics;1:181–9.Paika IJ, Lai F, McAllister NM, Miller WA, 1984. Thefragile-X marker survey: preliminary report on thescreening of suspected fragile X syndrome patients atthe Fernald State School. Am J Human Genetics;36:108S.Palomaki GE, 1994. Population based prenatal screeningfor the fragile X syndrome. J Med Screening;1:65–72.Palomaki GE, Haddow JE, 1993. Is it time for populationbasedprenatal screening for fragile-X? Lancet;341:373–4.Parrish JE, Oostra BA, Verkerk AJ, et al, 1994. Isolation ofa GCC repeat showing expansion in FRAXF, a fragile sitedistal to FRAXA and FRAXE. Nature Genetics;8:229–35.Partington MW, 1984. The fragile X syndrome II:preliminary data on growth and development in males.Am J Med Genetics;17:175–94.Partington MW, Robinson H, Laing S, Turner G, 1992.Mortality in the fragile X syndrome: preliminary data.Am J Med Genetics;43:120–3.Pennington BF, O’Connor RA, Sudhalter V, 1991.Towards a neuropsychology of fragile X syndrome.In: Hagerman RJ, Silverman AC. Fragile X syndrome:diagnosis, treatment and research. Baltimore: JohnsHopkins University Press.Pergolizzi RG, Erster SH, Goonewardena P, BrownWT, 1992. Detection of full fragile X mutation.Lancet;339:271–2.Pieretti M, Zhang FP, Fu YH, et al, 1991. Absence ofexpression of the FMR-1 gene in fragile X syndrome.Cell;66:817–22.Pintado E, de Diego Y, Hmadcha A, Carrasco M, SierraJ, Lucas M, 1995. Instability of the CGG repeat at theFRAXA locus and variable phenotypic expression ina large fragile X pedigree. J Med Genetics;32:907–8.Potter NT, Lozzio CB, Anderson IJ, Bowlin ES,Matteson KJ, 1992. Use of a molecular geneticapproach to diagnosing the fragile X genotype.J Ped;121:385–90.Primrose DA, El-Matmati R, Boyd E, Gosden C,Newton M, 1986. Prevalence of the fragile X syndromein an institution for the mentally handicapped.Br J Psychiatry;148:655–7.Prior TW, Papp AC, Snyder PJ, Sedra MS, Guida M,Enrile BG, 1995. Germline mosaicism at the fragileX locus. Am J Med Genetics;55:384–6.Puck JM, Stewart CC, Nussbaum RL, 1992. Maximumlikelihoodanalysis of human T-cell X chromosomeinactivation patterns: normal women versus carriersof X-linked severe combined immunodeficiency.Am J Human Genetics;50:742–8.Puissant H, Malinge MC, Larget-Piet A, et al, 1994.Molecular analysis of 53 fragile X families with theprobe StB12.3. Am J Med Genetics;53:370–3.Quan F, Zonana J, Gunter K, Peterson KL, MagenisRE, Popovich BW, 1995. An atypical case of fragile Xsyndrome caused by a deletion that includes the FMR1gene. Am J Human Genetics;56:1042–51.Reiss AL, Freund L, 1992. Behavioral phenotype offragile X syndrome: DSM-III-R autistic behavior inmale children. Am J Med Genetics;43:35–46.Reiss AL, Freund L, Abrams MT, Boehm C, KazazianH, 1993. Neurobehavioral effects of the fragile Xpremutation in adult women: a controlled study.Am J Human Genetics;52:884–94.Reiss AL, Kazazian HH Jr, Krebs CM, et al, 1994.Frequency and stability of the fragile X premutation.Human Molec Genetics;3:393–8.Reiss AL, Freund LS, Baumgardner TL, Abrams MT,Denckla MB, 1995. Contribution of the FMR1 genemutation to human intellectual dysfunction. NatureGenetics;11:331–4.Reyniers E, Vits L, De Boulle K, et al, 1993. The fullmutation in the FMR-1 gene of male fragile X patientsis absent in their sperm. Nature Genetics;4:143–6.Richards RI, Sutherland GR, 1992. Heritable unstableDNA sequences [news]. Nature Genetics;1:7–9.Richards RI, Sutherland GR, 1994. Simple repeat DNA isnot replicated simply. Nature Genetics;6:114–16.Richards RI, Holman K, Kozman H, et al, 1991. FragileX syndrome: genetic localisation by linkage mappingof two microsatellite repeats FRAXAC1 and FRAXAC2which immediately flank the fragile site. J MedGenetics;28:818–23.Richards RI, Holman K, Friend K, et al, 1992. Evidenceof founder chromosomes in fragile X syndrome.Nature Genetics;1:257–60.Richards RI, Holman K, Yu S, Sutherland GR, 1993. FragileX syndrome unstable element, p(CCG)n, and other simpletandem repeat sequences are binding sites for specificnuclear proteins. Human Molec Genetics;2:1429–35.Richards RI, Holman K, Friend K, et al, 1994a. FRAXAC2instability [letter; comment]. Nature Genetics;7:122–3.Richards RI, Kondo I, Holman K, et al, 1994b. Haplotypeanalysis at the FRAXA locus in the Japanese population.Am J Med Genetics;51:412–6.63
Page 1 and 2:
Health Technology Assessment 1997;
Page 5 and 6:
Screening for fragile X syndromeJen
Page 7:
Page 11 and 12:
Page 17 and 18:
Page 21 and 22:
Page 23 and 24: Health Technology Assessment 1997;
Page 29: Health Technology Assessment 1997;
Page 38 and 39: Screening and diagnosis26extended t
Page 50 and 51: Modelling allele dynamicsshown in T
Page 52 and 53: Modelling allele dynamicsTABLE 12 R
Page 54 and 55: Modelling allele dynamicsfrequency.
Page 56 and 57: Assessment of screening potentialac
Page 58 and 59: Human and financial costs of screen
Page 60 and 61: Human and financial costs of screen
Page 62 and 63: Recommendations5. A central registr
show all

Screening for Fragile X Syndrome (Murray et al.) - NIHR Journals ...

Create successful ePaper yourself

Delete template?

Save as template?